Cicatricial complications of respiratory papillomatosis surgical treatment at the department of Saint Petersburg State Pediatric Medical University clinical hospital in 2019–2021

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: Respiratory papillomatosis requires combined treatment, adjuvant therapy and surgical treatment. Scarring complications often occur after surgical treatment.

AIM: To determine the frequency of cicatricial complications of surgical treatment of respiratory papillomatosis in children.

MATERIALS AND METHODS: A retrospective analysis of the medical histories of 49 children who received surgical treatment at the clinic of the Saint Petersburg State Pediatric Medical University for 3 years (from 2019 to 2021) was carried out. The data obtained were compared with the data of a meta-analysis conducted in 2022.

RESULTS: In the otolaryngological department of Saint Petersburg State Medical University from 2019 to 2021, 49 children aged 1 to 17 years — 25 boys and 24 girls — received surgical treatment. Primary papillomatosis was detected in 9 patients. The first surgical intervention was at the age of 2 years in 12 children (24.5%). Combined treatment was used: endolaryngeal removal of laryngeal papillomas with microsurgical instruments and administration of interferon alpha-2b in the postoperative period. Of the 49 patients, scarring was detected in 16 (32.6%). However, 29 patients were operated only at the Saint Petersburg State Medical University clinic — the percentage of cicatricial complications among them was 20.6%. 20 patients turned to the Saint Petersburg State Medical University clinic after treatment in other institutions — the percentage of cicatricial complications among them was 50%. Of all 49 children examined, scarring occurred in the vocal region in 10 children (62.5%), in the larynx — in 2 children (12.5%), in both departments in 4 children (25%). Scarring changes were not detected in the sub-vocal part of the larynx. The number of operations per year for each child ranged from 1 to 7, and for 3 years (from 2019 to 2021), the number of operations reached 20.

CONCLUSIONS: Scarring complications after surgical treatment of respiratory papillomatosis are quite common. It was revealed that the first surgical treatment is more often in the first 3 years of life. The choice of surgical technique affects the frequency of cicatricial complications, however, it is extremely difficult to avoid cicatricial complications as long as there is a need for surgical treatment.

About the authors

Valery V. Dmitrenko

Saint Petersburg State Pediatric Medical University

Author for correspondence.
Email: dmitrenko1411@mail.ru
ORCID iD: 0000-0003-2766-6577

Otorhinolaryngologist, Department of Otorhinolaryngology

Russian Federation, Saint Petersburg

Pavel V. Pavlov

Saint Petersburg State Pediatric Medical University

Email: pvpavlov@mail.ru
ORCID iD: 0000-0002-4626-201X

MD, PhD, Dr. Sci. (Med.), Assistant Professor, Head of the Department of Otorhinolaryngology

Russian Federation, Saint Petersburg

Vyacheslav A. Verezgov

Saint Petersburg State Pediatric Medical University

Email: verezgov@gmail.com
ORCID iD: 0000-0001-5049-916X

MD, PhD, Cand. Sci. (Med.), Otorhinolaryngologist, Department of Otorhinolaryngology

Russian Federation, Saint Petersburg

Maria L. Zakharova

Saint Petersburg State Pediatric Medical University

Email: dr.essina@mail.ru
ORCID iD: 0000-0001-6410-3533

MD, PhD, Dr. Sci. (Med.), Assistant Professor of the Department of Otorhinolaryngology

Russian Federation, Saint Petersburg

Dmitry V. Breusenko

Saint Petersburg State Pediatric Medical University

Email: lor-gpma@mail.ru
ORCID iD: 0000-0003-2983-4124

MD, PhD, Cand. Sci. (Med.), Head of the Department of Otorhinolaryngology

Russian Federation, Saint Petersburg

Yulia A. Kuryanova

Saint Petersburg State Pediatric Medical University

Email: Julia_ku@mail.ru
ORCID iD: 0000-0003-3843-0201

Otorhinolaryngologist, Department of Otorhinolaryngology

Russian Federation, Saint Petersburg

Olga E. Kukushkina

Saint Petersburg State Pediatric Medical University

Email: o.lka@mail.ru
ORCID iD: 0000-0001-5351-3764

Otorhinolaryngologist, Department of Otorhinolaryngology

Russian Federation, Saint Petersburg

Oksana K. Gorkina

Saint Petersburg State Pediatric Medical University

Email: gorkina-ok@yandex.ru
ORCID iD: 0000-0002-2527-9023

Assistant of the Department Otorhinolaryngology

Russian Federation, Saint Petersburg

References

  1. Ashurov ZM, Zenger VG. Respiratornyi papillomatoz u detei. Moscow: Media-sfera, 2004. 208 p. (In Russ.)
  2. Vorontsov IM, Mazurin AV. Propedevtika detskikh boleznei. Saint Petersburg: Foliant, 2009. 1008 p. (In Russ.)
  3. Kolotilov LV, Pavlov VY. Characteristics of respiratory support in anesthesia of endolaryngeal operations. Pediatrician (St. Petersburg). 2013;4(1):65–70. (In Russ.) doi: 10.17816/PED4165-70
  4. Kucherova LR. Kliniko-immunologicheskoe obosnovanie mestnogo primeneniya rekombinantnogo interferona-al’fa2 v terapii retsidiviruyushchego respiratornogo papillomatoza [dissertation]. Moscow, 2011. (In Russ.)
  5. Svistushkin VM, Volkova KB. Sovremennoe sostoyanie problemy respiratornogo papillomatoza gortani. Russian Medical Journal. 2015;(23):1377–1380. (In Russ.)
  6. Soldatskiy Yu. Recurrent respiratory papillomatosis. Current Pediatrics. 2007;6(1):69–74. (In Russ.)
  7. Soldatsky YuL, Kiselev VI, Onufrieva EK, et al. Efficacy of indinol in antirecurrence therapy of juvenile respiratory papillomatosis. Bulletin of Otorhinolaryngology. 2006;(1):46–48. (In Russ.)
  8. Bishai D, Haskins K, Shah K. The cost of juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2000;126(8):935–939. doi: 10.1001/archotol.126.8.935
  9. Bomholt A. Juvenile laryngeal papillomatosis. An epidemiological study from the Copenhagen region. Acta Otolaryngol. 1988;105(3–4): 367–371. doi: 10.3109/00016488809097020
  10. Bomholt A. Laryngeal papillomas with adult onset. An epidemiological study from the Copenhagen region. Acta Otolaryngol. 1988;106(1–2):140–144. doi: 10.3109/00016488809107381
  11. Campisi P. Recurrent respiratory papillomatosis. Springer Cham, 2007. 196 p. doi: 10.1007/978-3-319-63823-2
  12. Carvalho CM, Huot L, Charlois AL, et al. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients. Acta Otolaryngol. 2009;129(4):462–470. doi: 10.1080/00016480902737986
  13. Cui S, Han D, Chen X, et al. Clinical study of juvenile-onset recurrent respiratory papillomatosis. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2001;36(6):458–462.
  14. Dedo HH, Yu KCYu. CO(2) laser treatment in 244 patients with respiratory papillomas. Laryngoscope. 2001;111(9):1639–1644. doi: 10.1097/00005537-200109000-00028
  15. Derkay CS, Volsky PG, Rosen CA, et al. Current use of intralesional cidofovir for recurrent respiratory papillomatosis. Laryngoscope. 2013;123(3):705–712. doi: 10.1002/lary.23673
  16. Derkay CS. Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121(12): 1386–1391. doi: 10.1001/archotol.1995.01890120044008
  17. El-Bitar MA, Zalzal GH. Powered instrumentation in the treatment of recurrent respiratory papillomatosis: an alternative to the carbon dioxide laser. Arch Otolaryngol Head Neck Surg. 2002;128(4):425–428. doi: 10.1001/archotol.128.4.425
  18. Fortes HR, von Ranke FM, Escuissato DL, et al. Recurrent respiratory papillomatosis: A state-of-the-art review. Respir Med. 2017;126:116–121. doi: 10.1016/j.rmed.2017.03.030
  19. Goon P, Sonnex C, Jani P, et al. Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol. 2008;265(2):147–151. doi: 10.1007/s00405-007-0546-z
  20. Hester RP, Derkay CS, Burke BL, Lawson ML. Reliability of a staging assessment system for recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2003;67(5):505–509. doi: 10.1016/s0165-5876(03)00007-7
  21. Hock K, Kennedy A, Howell R, et al. Surgery and adjuvant therapy improve Derkay scores in adult and pediatric respiratory papillomatosis. Laryngoscope. 2022;132(12):2420–2426. doi: 10.1002/lary.30042
  22. Katsenos S, Becker HD. Recurrent respiratory papillomatosis: a rare chronic disease, difficult to treat, with potential to lung cancer transformation: apropos of two cases and a brief literature review. Case Rep Oncol. 2011;4(1):162–171. doi: 10.1159/000327094
  23. Komloš KF, Kocjan BJ, Košorok P, et al. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol. 2012;84(8):1233–1241. doi: 10.1002/jmv.23318
  24. Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis. APMIS. J Pathol Microbiol Immunol. 2010;118(6–7): 450–454. doi: 10.1111/j.1600-0463.2010.02619.x
  25. Lawlor C, Balakrishnan K, Bottero S, et al. International Pediatric Otolaryngology Group (IPOG): Juvenile-onset recurrent respiratory papillomatosis consensus recommendations. Int J Pediatr Otorhinolaryngol. 2020;128:109697. doi: 10.1016/j.ijporl.2019.109697
  26. Liu S, Wang J, Shao J. Safety of different surgical modalities for recurrent respiratory papillomatosis resection: A systematic review and meta-analysis. Clin Otolaryngol. 2023;48(3):403–413. doi: 10.1111/coa.14023
  27. Novakovic D, Cheng ATL, Zurynski Y, et al. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. 2018;217(2):208–212. doi: 10.1093/infdis/jix498
  28. Papaioannou V-A, Lux A, Voigt-Zimmermann S, Arens C. Treatment outcomes of recurrent respiratory papillomatosis: Retrospective analysis of juvenile and adult cases. HNO. 2018;66(S1):7–15. doi: 10.1007/s00106-017-0378-0
  29. Scatolini ML, Labedz G, Cocciaglia A, et al. Laryngeal sequelae secondary to surgical treatment for recurrent respiratory papillomatosis in children. Int J Pediatr Otorhinolaryngol. 2020;130:109815. doi: 10.1016/j.ijporl.2019.109815
  30. Seedat RY, Dikkers FG. Global epidemiology of HPV-associated recurrent respiratory papillomatosis and effect of vaccination. Future Virol. 2022;17(5):fvl-2021–0278. doi: 10.2217/fvl-2021-0278
  31. Seedat RY. Juvenile-onset recurrent respiratory papillomatosis diagnosis and management — A developing country review. Pediatric Health Med Ther. 2020;11:39–46. doi: 10.2147/PHMT.S200186
  32. Seedahmed KMS, El-Haj AH, Bashir AMA. Recurrent respiratory papillomatosis: clinical presentation, treatment modalities, and outcomes in Khartoum state. Egypt J Otolaryngol. 2022;38:38. doi: 10.1186/s43163-022-00227-9
  33. Ushikai M, Fujiyoshi T, Kono M, et al. Detection and cloning of human papillomavirus DNA associated with recurrent respiratory papillomatosis in Thailand. Jpn J Cancer Res. 1994;85(7):699–703. doi: 10.1111/j.1349-7006.1994.tb02417.x
  34. Welschmeyer A, Berke GS. An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol. 2021;6(2):226–233. doi: 10.1002/lio2.521
  35. Wilcox LJ, Hull BP, Baldassari CM, Derkay CS. Diagnosis and management of recurrent respiratory papillomatosis. J Pediatr Infect Dis. 2014;3(12):1283–1284. doi: 10.1097/INF.0000000000000551

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. The first surgical treatment for respiratory papillomatosis in children

Download (122KB)
3. Fig. 2. The number of surgeries for respiratory papillomatosis that one patient required in 3 years

Download (144KB)
4. Fig. 3. The ratio of scar complications in the larynx by localization after surgical treatment of respiratory papillomatosis

Download (99KB)

Copyright (c) 2023 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies